 NEW YORK, Nov. 02, 2020 GLOBE NEWSWIRE -- Delcath Systems, Inc. NASDAQ: DCTH, an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today announced that it will host a conference call on November 11, 2020 at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2020. 